Cargando…

Mechanism of epithelial-mesenchymal transition inhibited by miR-203 in non-small cell lung cancer

The aim of the present study was to investigate whether miR-203 can inhibit transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition (EMT), and the migration and invasion ability of non-small cell lung cancer (NSCLC) cells by targeting SMAD3. In the present study, the expressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Weicong, Wu, Yuanbo, Cheng, Dezhi, He, Zhifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967097/ https://www.ncbi.nlm.nih.gov/pubmed/31894278 http://dx.doi.org/10.3892/or.2019.7433

Ejemplares similares

MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2
por: Liao, Hongzhan, et al.
Publicado: (2015)

The mechanisms of colorectal cancer cell mesenchymal-epithelial transition induced by hepatocyte exosome-derived miR-203a-3p
por: Xu, Heyang, et al.
Publicado: (2021)

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
por: Qin, Haifeng, et al.
Publicado: (2015)

HOTAIR Contributes to Stemness Acquisition of Cervical Cancer through Regulating miR-203 Interaction with ZEB1 on Epithelial-Mesenchymal Transition
por: Zhang, Wenying, et al.
Publicado: (2021)

Rewiring of an Epithelial Differentiation Factor, miR-203, to Inhibit Human Squamous Cell Carcinoma Metastasis
por: Benaich, Nathan, et al.
Publicado: (2014)

Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203
por: Gu, Yulei, et al.
Publicado: (2020)

miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition
por: Wang, Lin, et al.
Publicado: (2015)

Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition
por: Haraguchi, Takeshi, et al.
Publicado: (2016)

MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition
por: DeCastro, A J, et al.
Publicado: (2013)

miR‐203 inhibits cell proliferation, invasion, and migration of non‐small‐cell lung cancer by downregulating RGS17
por: Chi, Yongbin, et al.
Publicado: (2017)

miR-145 and miR-497 suppress TGF-β-induced epithelial–mesenchymal transition of non-small cell lung cancer by targeting MTDH
por: Yin, Qi, et al.
Publicado: (2018)

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer
por: Yu, Jingshuang, et al.
Publicado: (2014)

miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2
por: Tu, Bing, et al.
Publicado: (2016)

miR-203 contributes to pre-eclampsia via inhibition of VEGFA expression
por: Liu, Fulin, et al.
Publicado: (2018)

miR-203 Inhibits Cell Proliferation and Migration of Lung Cancer Cells by Targeting PKCα
por: Wang, Chen, et al.
Publicado: (2013)

miR-32 inhibits proliferation, epithelial–mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells
por: Li, Lei, et al.
Publicado: (2016)

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
por: Hiramoto, Hidekazu, et al.
Publicado: (2017)

MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
por: Lu, Yuhua, et al.
Publicado: (2014)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017)

MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer
por: Liu, Min-Xia, et al.
Publicado: (2014)

MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer
por: Jiang, Kanqiu, et al.
Publicado: (2019)

Downregulation of SOX2 may be targeted by miR-590-5p and inhibits epithelial-to-mesenchymal transition in non-small-cell lung cancer
por: Chang, Zhibo
Publicado: (2019)

MiR‐338 regulates NFATc1 expression and inhibits the proliferation and epithelial‐mesenchymal transition of human non‐small‐cell lung cancer cells
por: He, Wei, et al.
Publicado: (2019)

Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
por: Li, Yajuan, et al.
Publicado: (2013)

miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1
por: Cheng, Xiao-Yu, et al.
Publicado: (2018)

NORAD regulates epithelial-mesenchymal transition of non-small cell lung cancer cells via miR-422a
por: Chen, Zhikun, et al.
Publicado: (2021)

NORAD regulates epithelial-mesenchymal transition of non-small cell lung cancer cells via miR-422a
por: Chen, Zhikun, et al.
Publicado: (2021)

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)

miR-203 drives breast cancer cell differentiation
por: Martínez-Illescas, Nuria G., et al.
Publicado: (2023)

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
por: Navarro, A, et al.
Publicado: (2016)

MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
por: Cao, Lanqin, et al.
Publicado: (2018)

MiR-30a Inhibits the Epithelial—Mesenchymal Transition of Podocytes through Downregulation of NFATc3
por: Peng, Rui, et al.
Publicado: (2015)

MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma
por: Wang, Xingqiang, et al.
Publicado: (2017)

miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
por: Chen, Jing-Song, et al.
Publicado: (2016)

circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
por: Zhang, Xianwei, et al.
Publicado: (2018)

A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194
por: Bencivenga, Maria, et al.
Publicado: (2020)

miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
por: Yu, Yong-Zheng, et al.
Publicado: (2021)

MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells
por: Chen, Xun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1jsmo6po8f77psstqkkchfok4q